In addition to sperm cells, seminal fluid contains various small membranous vesicles. These include prostasomes, membrane vesicles secreted by prostate epithelial cells. Prostasomes have been proposed to perform a variety of functions, including modulation of (immune) cell activity within the female reproductive tract and stimulation of sperm motility and capacitation. How prostasomes mediate such diverse functions, however, remains unclear. In many studies, vesicles from the seminal plasma have been categorized collectively as a single population of prostasomes; in fact, they more likely represent a heterogeneous mixture of vesicles produced by different reproductive glands and secretory mechanisms. We here characterized membranous vesicles from seminal fluid obtained from vasectomized men, thereby excluding material from the testes or epididymides. Two distinct populations of vesicles with characteristic sizes (56 6 13 nm vs. 105 6 25 nm) but similar equilibrium buoyant density (;1.15 g/ml) could be separated by using the distinct rates with which they floated into sucrose gradients. Both types of vesicle resembled exosomes in terms of their buoyant density, size, and the presence of the ubiquitous exosome marker CD9. The protein GLIPR2 was found to be specifically enriched in the lumen of the smaller vesicles, while annexin A1 was uniquely associated with the surface of the larger vesicles. Prostate stem-cell antigen (PSCA), a prostatespecific protein, was present on both populations, thereby confirming their origin. PSCA was, however, absent from membrane vesicles in the seminal fluid of some donors, indicating heterogeneity of prostasome characteristics between individuals.
INTRODUCTION
In addition to sperm cells and soluble molecules, mammalian semen contains a variety of membranous vesicles. Among these are prostasomes [1, 2] and epididymosomes [3] , which are derived from prostatic and epididymal epithelial cells, respectively. Other tissues within the male genital tract, such as the vesicular glands, which produce the majority of seminal fluid, and the vasa deferentia, may also contribute membrane vesicles to the seminal plasma [3, 4] . In this respect, while the term prostasomes is often used to refer to the collective array of membrane vesicles isolated from seminal plasma [5] [6] [7] [8] , it would be more appropriate to define prostasomes as those membrane vesicles that are actually produced by the prostatic epithelium. Prostasomes are ;0.1 lm vesicles that have been proposed to be formed within multivesicular bodies in prostate epithelial cells and released into the seminal fluid following fusion of these multivesicular bodies with the plasma membrane of the containing cell [1, 9, 10] . As such, prostasomes can be classified as exosomes. Exosomes are secreted by many different cell types [9] and have been found in most other body fluids, including blood, urine, saliva, cerebrospinal fluid, and peritoneal fluid in patients with malignant ascites [11] [12] [13] [14] [15] [16] .
Unlike prostasomes, epididymosomes have a diameter up to 250 nm and are thought to be shed directly from the plasma membrane of epididymal epithelial cells [17] . In general, membrane vesicles that are released by shedding from the cell plasma membrane are referred to as microvesicles or ectosomes [16] . According to this definition, epididymosomes are microvesicles/ectosomes rather than exosomes. Epididymosomes are known to transfer proteins from the epididymal epithelium to passing sperm cells [18] .
Prostasomes have been proposed to function in many different processes [19] , including stimulation of sperm cell motility [20] through delivery of Ca 2þ signaling tools [21] and either inhibition [22] or stimulation [23] of the acrosome reaction. Prostasomes could also help to protect sperm cells from immune responses within the female reproductive tract by, for example, inhibiting the complement pathway [24, 25] , inhibiting lymphocyte proliferation [26] , and inhibiting monocyte and neutrophil phagocytosis [27] , possibly via contained immunomodulatory proteins such as galectin 3 [8] or CD48 [28] . Although it is possible that a single type of prostasome is able to function in a variety of seemingly unrelated processes, we consider it more likely that distinct populations of vesicles carry out different tasks. Understanding the function of seminal membrane vesicles in reproductive processes would therefore benefit greatly from a better characterization of the distinct populations of vesicles present. We therefore set out to develop procedures to isolate and characterize subtypes of membrane vesicles from human seminal fluid. To exclude contamination by sperm and epididymis-derived membrane vesicles, we used seminal plasma from vasectomized men as starting material. From this source, two distinct types of prostasomes could be defined based on their size and molecular composition.
MATERIALS AND METHODS

Prostasome Isolation and Fractionation
Informed consent was obtained from all the patients, and the investigations were approved by the Medical Ethics Committee at Meander Medical Centre. Human semen was obtained from vasectomized men following a postoperative period of .3 mo and an indication of at least 15 ejaculations. After centrifugation at 3000 3 g for 10 min, the absence of sperm cells in the pellet was considered indicative of the absence of any residual material from the testes or epididymides. The resulting supernatants were pooled from five to seven patients per batch, diluted 1:1 in phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , pH 7.4), and cleared of large particles by centrifuging twice at 10 000 3 g for 20 min. To collect membrane vesicles and separate them from soluble proteins, the supernatant was loaded onto 3 ml of 0.7 M sucrose in PBS containing 1 mg/ml bovine serum albumin (PBS/BSA) that itself had been overlaid onto 4 ml of 2 M sucrose in PBS/BSA. The layered tube was then centrifuged at 100 000 3 g for 75 min in an SW28 rotor (Beckman Instruments, Inc.). The membranecontaining fraction (1-2 ml) was collected from the interface between the two sucrose layers. For size fractionation, membrane fractions were applied onto a 700 3 26 mm preequilibrated Sephacryl S-1000 gel filtration column (GE Healthcare) and eluted with PBS/BSA containing 0.02% sodium azide at 48C. Eluted column fractions of 2 ml were analyzed for the presence of total protein, CD9, and prostate stem-cell antigen (PSCA), as described below.
In a subsequent fractionation step, column fractions containing CD9 and PSCA were pooled and collected by ultracentrifugation at the interface of a 0.7 M/2.0 M sucrose block gradient as described above. Membrane vesicles were then separated on linear sucrose density gradients either by sedimentation or floatation. For sedimentation experiments, vesicles were diluted with PBS/ BSA, loaded on top of a linear sucrose gradient (2.0-0.4 M sucrose in PBS/ BSA) in a SW60 tube (Beckman Instruments) and centrifuged for 62 h at 190 000 3 g. For floatation experiments, solid sucrose was dissolved in the isolated interface from the 0.7 M/2.0 M sucrose block gradient to a final concentration of 2.5 M. The contained vesicles were then floated into an overlaid linear sucrose gradient (2.0-0.4 M sucrose in PBS plus 1 mg/ml BSA) by centrifugation either in a SW60 or SW40 tube (Beckman Instruments) for 64 or 16 h at 190 000 3 g as indicated. Gradient fractions of 1 ml were collected from the bottom of the tubes and analyzed for the presence of protein, CD9, and PSCA as described below. Fraction densities were determined by refractometry. When indicated, prostasomes from individual vasectomized donors were collected directly from seminal fluid by sedimentation at 100 000 3 g for 45 min (TLA-55 rotor; Beckman Instruments) after the large particles had been cleared by centrifugation for 12 min at 10 000 3 g.
SDS-PAGE, Immunoblotting, and Silver Staining
For Western blotting, samples were separated by 12.5% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). PVDF membranes were blocked in PBS containing 5% (w/v) nonfat dry milk (Protifar plus; Nutricia) and 0.1% (v/v) Tween-20. For detection of CD9, blots were probed and immunolabeled in the same buffer with either mouse anti-human CD9 (clone HI9a; 1:500; Santa Cruz Biotechnology Inc.), which recognizes only nonreduced CD9, or rabbit anti-human CD9 (1:500; Abcam), which sees only reduced CD9. Other blots were probed with mouse anti-human PSCA (clone 7F5; 1:1000; Santa Cruz Biotechnology Inc.), rabbit anti-human PSCA (1:250; Acris Antibodies Inc.), rabbit anti-human GLIPR2 [29] (1:5000), or mouse anti-human annexin A1 (clone 29; 1:250; BD Biosciences) [30] . Primary antibodies were probed with horseradish peroxidase-conjugated secondary antibodies (1:10 000; Pierce Biotechnology) and detected using Supersignal west pico chemiluminescent substrate (Pierce Biotechnology) on film or with a ChemiDocXRS device (Bio-Rad). For total protein detection, gels were fixed in 50% ethanol plus 5% acetic acid for 1 h and silver stained.
Mass Spectrometry
Bands were excised from silver-stained gels, reduced with dithiothreitol, alkylated with iodoacetamide, and digested with trypsin (Roche, Indianapolis, IN) as described [31] . Samples were subjected to nanoflow LC (Eksigent) using C 18 reverse-phase trap columns (Phenomenex; column dimensions: 2 cm 3 100 lm, packed in-house) and subsequently separated on C 18 analytical columns (Dr. Maisch HPLC Gmbh; Reprosil column dimensions: 20 cm 3 50 lm, packed in-house) using a linear gradient of 0% to 40% B in A (A ¼ 0.1 M acetic acid; B ¼ 95% (v/v) acetonitrile and 0.1 M acetic acid) for 60 min and at a constant flow rate of 150 nl/min. The column eluate was directly coupled to a LTQ-Orbitrap-XL mass spectrometer (Thermo Fisher Scientific) operating in positive mode, using Lock spray internal calibration. The data were processed and subjected to database searches using MASCOT software (Matrixscience) against Swiss Prot and nonredundant NCBI database, with a 10 ppm mass tolerance of the precursor and 0.8 Da for the fragment ion.
Sizing of Membrane Vesicles by Nanoparticle Tracking Analysis
For vesicle size determination by nanoparticle tracking analysis (NTA), the Brownian motion of the vesicles was followed using the NanoSight LM10SH (NanoSight), equipped with a sample chamber with a 532 nm laser. The samples were measured for 180 s at 208C. The shutter and gain were adjusted manually and were equal for all the measurements. The data was captured and analyzed using the Nanoparticle Tracking Analysis 2.1 software (NanoSight). At least six individual measurements with a total of at least 2500 tracks for individually traced particles were detected for each condition.
Immunoelectron Microscopy
For electron microscopic analysis, whole mount preparations were made essentially as described previously [32] . In short, isolated vesicles were diluted in PBS, collected by centrifugation at 107 000 3 g for 35 min in a TLA-55 rotor (Beckman Instruments), and resuspended in PBS. Vesicles were bound to Formvar-carbon coated copper grids (CMC) for 20 min, washed with PBS, and blocked for 30 min in PBS containing 5% BSA and 0.1% cold water fish skin gelatin (Sigma-Aldrich Chemie Gmbh, Germany). Subsequently, grids were probed with either 5 lg/ml anti-PSCA antibody (clone 7F5) or 10 lg/ml anti-CD9 antibody (clone MM2/57) in PBS containing 0.1% acetylated BSA and then washed with the same buffer. For PSCA labeling, grids were subsequently probed with 50 lg/ml rabbit anti-mouse immunoglobulins (DakoCytomation) as bridging antibodies. All the grids were labeled with 20 nm protein A gold (CMC) in incubation buffer. After labeling and washing, the grids were fixed with 4% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.6), washed with water, and treated with 2% uranyl acetate as the contrast medium. Samples were imaged using a Tecnai10 electron microscope (FEI) equipped with a SIS CCD MegaView II camera. Images were analyzed using AnalySISpro software (Olympus). Tiff images were contrast enhanced using a CLAHE plug-in, and particle measurement (.100 vesicles per group) was performed using ImageJ 1.43m software. Average Feret diameters were compared using an independent samples t-test, and the percentages of electron dense vesicles were compared with a v 2 -test (SPSS 16.0 software).
RESULTS
Seminal fluid was obtained from healthy vasectomized men, thereby excluding potential contributions from the testis and epididymis. Membrane vesicles in pooled seminal fluid from five to seven donors were first isolated and separated from soluble molecules by ultracentrifugation through 0.7 M sucrose layered onto a 2 M sucrose cushion to prevent membrane aggregation. Membrane vesicles were collected from the 0.7 M/2 M sucrose interface and fractionated by size using a Sephacryl S-1000 gel filtration column. Protein-containing fractions were identified and immunoblotted for CD9 and PSCA (Fig. 1A ). CD9 and PSCA have both previously been identified on membrane vesicles from human seminal plasma using a mass spectrometric approach [33] . In addition, the tetraspanin membrane protein CD9 was used as a presumptive marker protein for prostasomes because of its ubiquitous presence on exosomes from many other sources [34, 35] . Both CD9 and PSCA partly eluted in the void volume (fractions 28-32), whereas the majority was retained by the column and eluted in later fractions. The major band for nonreduced CD9 migrated at approximately 24 kDa, matching the mobility of CD9 in exosomes from other sources, including urine (data not shown). The antibody used only detects nonreduced CD9 and labeled two additional minor bands that ran just above and below the major 24 kDa band. These bands represented CD9 molecules with different intramolecular disulfide linkages [36] , which was confirmed using another antibody that recognizes reduced CD9 as a single band (Supplemental Figure S1 , available online at www.biolreprod.org). PSCA was detected AALBERTS ET AL.
on Western blots as a smear running from 20 to 40 kDa, depending on its degree of glycosylation, which is consistent with previous reports [37] . Like CD9, PSCA was found both in the void volume and in retained fractions. Whole mount electron microscopic analysis indicated that membranes that eluted in the column's void volume contained filamentous structures of about 300-400 nm in length, heterogeneously sized large vesicles of up to 300 nm in diameter (average 131 6 57 nm), and aggregated smaller vesicles (Fig. 1B) . In contrast, pooled vesicles that eluted in fractions 44-54 were on average smaller (74 6 26 nm) than those from the column void volume and were mostly not aggregated (Fig. 1C) .
Membrane vesicles that eluted from the column in fractions 44-54 were pooled and further purified on density sucrose gradients. After spinning for 64 h at 190 000 3 g, CD9 was recovered at a density of approximately 1.15 g/ml irrespective of whether the vesicles were loaded on top ( Fig. 2A) or at the bottom (Fig. 2B ) of the sucrose gradient, demonstrating that the vesicles had reached their equilibrium buoyant density. The same profiles were observed for PSCA (data not shown). Such equilibrium densities are characteristic of exosomes [16, 38] . By contrast, when the vesicles were floated from the bottom of the tube up into the sucrose density gradients for only 16 h at 190 000 3 g, two distinct populations were discerned (Fig. 2C) . One population contained CD9 and PSCA and floated into the gradient to fractions with densities of 1.09-1.16 g/ml, indicating that they had already reached their equilibrium density after 16 h of centrifugation. The second population also contained CD9 and PSCA but was recovered from the lower gradient fractions, with densities of 1.23-1.26 g/ml. The rate at which vesicles migrate to their equilibrium density is influenced not only by their intrinsic density, but also by their size. As a result, we suspected that vesicles in the lower gradient fractions were smaller than those that had migrated to the middle of the gradient after 16 h of centrifugation. Size determination by NTA indeed indicated that membrane vesicles from the lower gradient fractions were smaller (mean of 72 6 0.2 nm, n ¼ 2 independent experiments) than those collected from the middle of the sucrose gradient (mean of 105 6 13.0 nm). This method does not however discriminate between single and possibly aggregated vesicles. Therefore, accurate sizes of individual vesicles were determined by electron microscopy ( Fig. 3 and Table 1 ). Vesicles from the lower gradient fractions were indeed significantly smaller (56 6 13 nm) than those from the middle gradient fractions (105 6 25 nm). Vesicles within the first pool (small vesicles) had an electron-lucent appearance, while most vesicles in the second pool displayed a more contrasted core. Many vesicles from both the lower and middle gradient fractions were positive for immunolabeling with colloidal gold for CD9. As a DISTINCT PROSTASOMES IN HUMAN SEMINAL PLASMA result of the relatively low average labeling density with gold particles (with an average of 1.3 gold particles per CD9-positive vesicle from high-density fractions and 2.5 for vesicles from low-density fractions), however, this approach did not allow us to draw conclusions with regard to the possible presence of CD9-negative vesicles. Labeling efficiencies for PSCA were higher: 2.6 and 4.7 gold particles per PSCA labeled vesicle in high-and low-density fractions, respectively. Because only 14% and 36% of vesicles in the high-and lowdensity fractions, respectively, were labeled for PSCA, the data suggested that both PSCA-positive and PSCA-negative vesicles were present in pooled donor samples. This prompted us to check whether there was heterogeneity in the degree to which PSCA is present on prostasomes from individual donors. Strikingly, while all the samples from 22 individual donors contained CD9, 9 out of 22 donors either completely lacked or contained only very little PSCA on their presumptive prostasomes (Fig. 4, indicating 12 from 22 donors analyzed) . The same person-to-person variability was detected with PSCA directed monoclonal and unrelated polyclonal antibodies, indicating that absence of a PSCA signal was not due to heterogeneity in the availability of epitopes between individuals.
Next, we searched for differences in molecular composition between small and large prostasomes. To this end, proteins from sucrose gradient fractions from pooled donor samples were separated by SDS-PAGE and silver stained (Fig. 5A) . Several protein bands appeared to be exclusive for either highdensity or low-density fractions. Such bands were excised from the gel and analyzed by mass spectrometry (LC-MS/MS). In high-density fractions, the following proteins were identified: GLI pathogenesis-related 2 (GLIPR2; gi 55662094), gammaglutamyltransferase-like 4 isoform (gi 218505805), and prolactin-induced protein (gi 116642261). In low-density fractions, we found sorbitol dehydrogenase (gi 46015225), annexin A1 (gi 57829895), and dicarbonyl/L-xylulose reductase (gi 119610138). To confirm whether these proteins are indeed selectively associated with either one of the two prostasomes populations, immunoblot analysis was required; while we failed to detect most of these proteins because of the lack of proper antibodies, we were able to confirm the identity of GLIPR2 (17 kDa) and annexin A1 (40 kDa) (Fig. 5B) .
FIG. 3.
Membrane vesicles from high-and low-density fractions are distinct in size but both contain CD9 and PSCA. Two vesicle populations were separated by sucrose gradient fractionation as indicated in Figure 2C . Vesicles from high-and low-density fractions were immobilized, immunogoldlabeled for CD9 or PSCA, and analyzed by whole mount transmission electron microscopy. Representative pictures from two independent experiments are shown. Labeled vesicles are indicated by arrows. Bars ¼ 500 nm. Vesicle mean sizes and percentages of vesicles labeled for CD9 or PSCA are indicated in Table 1 .
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GLIPR2 was almost exclusively present on small prostasomes (Fig. 5B) . Given that GLIPR2 is a cytoplasmic protein, we expected it to be oriented toward the prostasome lumen. This orientation was confirmed by a protease protection assay; while GLIPR2 in intact prostasomes was resistant to exogenously added proteinase K, it was digested in the concomitant presence of the membrane disrupting agent 3-[(3-chloramidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) (Fig.  6) . In contrast to GLIPR2, Annexin A1 specifically associated with fractions containing large prostasomes (Fig. 5) . Annexin A1, like GLIPR2, does not have a signal sequence but is known to be secreted by the prostate via an unidentified alternative secretory pathway [39] . We found that annexin A1, in contrast to GLIPR2, was already digested by proteinase K in the absence of CHAPS (Fig. 6 ), indicating association with the prostasome exoplasmic surface.
DISCUSSION
This study demonstrates that membrane vesicles in seminal plasma of postepididymal origin are heterogeneous in terms of size and protein composition. Two distinct vesicle populations were discerned and purified: 1) ;56 nm vesicles that are specific for the presence of GLIPR2 and 2) ;105 nm vesicles that specifically carry annexin A1. The characteristics of both vesicle populations, including the presence of CD9, their size range, and characteristic equilibrium buoyant density, resemble those of exosomes [16, 38] . Like CD9, PSCA was detected in both populations, indicating the prostate as their origin and thereby qualifying them as prostasomes. The heterogeneity in size of these vesicles is consistent with the reported characteristics of prostasomes isolated directly from the prostate or from prostate tumors [1, 40] . Membrane vesicles were isolated and purified from seminal fluid of healthy vasectomized men, thereby excluding potential contributions from the testis and epididymis. In our first purification step, membrane vesicles of a size typical for exosomes (;50-100 nm) [16] were successfully separated from vesicle aggregates and larger membrane fragments by size-exclusion column chromatography. Vesicles with a diameter of up to 300 nm that separated in the void volume may include plasma-membrane derived microvesicles or apoptotic bodies [16, 41] . The retained vesicles were heterogeneous in size, in accordance with the structural heterogeneity of seminal membrane vesicles as recently described by others [33] . The latter study demonstrated three vesicle types based on morphological criteria observed by cryoelectron microscopic tomography: 1) 100-200 nm electron-dense vesicles with a smooth surface enveloping one or more secondary structures, 2) 50-200 nm electron-lucent vesicles displaying a rough surface, and 3) up to 400 nm elongated electron-lucent vesicles. The first category most The percentages of vesicles from high and low density fractions that were labeled with ! 1 gold particle for CD9 or PSCA are indicated, along with the average number of gold particles per labeled vesicle (in brackets). * Values indicate significant differences (P , 0.01).
FIG. 4.
PSCA is absent on prostasomes from some individual donors. Prostasomes were collected from the seminal fluid of individual donors (1-12) and immunoblotted for CD9 (A). The samples were probed on parallel blots for PSCA using mouse anti-human PSCA (B) or rabbit antihuman PSCA (C). Molecular weight markers are indicated on the right (M r 3 10
À3
).
FIG. 5. Small and large prostasomes have a distinct protein composition.
Two vesicle populations were separated by sucrose gradient fractionation, as in Figure 2C , and analyzed by SDS-PAGE and silver staining (A).
Proteins that appeared selectively enriched in either high-(arrows) or lowdensity fractions (arrowheads) were excised from the gel and analyzed by LC-MS/MS. BSA (indicated by an asterisk) was added to the gradient to prevent vesicle aggregation and is thus present in all the fractions. B) Confirmation of the near exclusive presence of GLIPR2 in high-density fractions and annexin A1 in low-density fractions by immunoblotting samples of the fractions from the same experiment. C) To increase the signal for annexin A1, the experiment in B was repeated with more starting material.
DISTINCT PROSTASOMES IN HUMAN SEMINAL PLASMA likely corresponds to, and includes, our ;105 nm electrondense vesicles; the second may include our ;56 nm electronlucent vesicles; and the third presumably corresponds to the membranes that we discarded in the void volume from the Sephacryl S-1000 column. Our study demonstrates that the first two vesicle types can be separated by employing the different rates by which they floated into sucrose density gradients. Our study is the first to describe PSCA as a marker of membrane vesicles in seminal plasma. PSCA is a glycophosphatidylinositol-anchored multiple N-glycosylated protein that, in addition to being found in the prostate, is also expressed by some other tissues, including placenta, kidney, and stomach. Its expression in the male reproductive tract, however, is confined to the prostate [42] [43] [44] . PSCA was previously found by mass spectrometric analysis to be present on membrane vesicles from human seminal plasma [33] but is also found in urinederived exosomes [11] . We therefore considered the possibility that our seminal fluid samples might have been contaminated with urine-derived exosomes. However, although exosomes isolated from 20-ml urine samples from four independent male donors clearly contained CD9, PSCA could not be detected by immunoblotting, excluding the possibility that PSCA-carrying vesicles isolated from seminal plasma originated from urine (data not shown). PSCA expression in the prostate is largely confined to its secretory epithelium [45] , although one study reported also some expression by basal epithelial cells and neuroendocrine cells [46] . Given the prominent expression of PSCA by prostate epithelial cells, it is likely that isolated PSCA-carrying exosomes are derived from this source. The mechanism for translocation of prostasomes from the interior of the prostate epithelial cells to the acinar lumen involves exocytosis of multivesicular bodies [47] , reminiscent of the mechanism by which exosomes are secreted by other cell types [16] . Interestingly, although all the tested individual donors produced CD9-carrying exosomes in their seminal plasma, not all the samples contained PSCA. The reason for this difference between donors remains unresolved. One possible explanation for the absence of PSCA-containing prostasomes is that prostates of some individuals may produce little if any PSCA. We found no correlation between the age (ranging from 32 to 53 yr) and the presence or absence of PSCA on prostasomes. PSCA expression in human prostate carcinoma is suppressed by androgen ablation [48] . Therefore, the presence of PSCA on prostasomes may be influenced by the androgen status of healthy donors. Given that prostasomes were routinely isolated from vasectomized healthy donors and the vasectomy procedure does not include determination of serum androgen levels, we were unable to test whether the person-to-person variability PSCA on prostasomes correlated with androgen titers in this study. As an alternative explanation for the lack of PSCA in prostasomes of some individuals, PSCA may fail to incorporate because of alternate sorting during prostasomes biogenesis or the absence of prostasomes secretion altogether. In the latter scenario, persisting CD9-containing vesicles may also originate from other sources. Semen contains products of the testes, epididymides, vasa deferentia, prostate, vesicular glands, and bulbourethral glands. Given that semen from vasectomized men was used as a source, membrane vesicles that are known to be produced by the epididymis (i.e., epididymosomes) [17] as well as any that may be generated within the testis or shed from the plasma membrane of (developing) sperm cells can be excluded. By contrast, the vesicular glands, terminal vas deferens, or bulbourethral glands may all contribute membrane PSCA-negative CD9-positive vesicles [4] .
The function of PSCA is unknown. PSCA-knockout mice are normally fertile [49] , and PSCA does therefore not seem to play an essential role in reproduction. Interestingly, PSCA has been proposed to act as an inhibitor of tumor development [44] and metastasis [49] . Such observations do not suggest any obvious function for PSCA on prostasomes. However, given that PSCA expression is contact dependent, its function might be related to cell adhesion [50] . Together with the current interest in PSCA as a biomarker for prostate cancer [51] , our observation that PSCA is present on (a subset of) prostasomes of some individuals but not of others suggests that PSCApositive prostasomes may be of value as a biomarker for the development of prostate hyperplasia or cancer. This is however beyond the scope of the current study. Prostate-specific antigen, which is an established biomarker for prostate cancer, was not detected on prostasomes in our study (data not shown).
GLIPR2 was found to reside exclusively in the lumen of ;56 nm prostasomes. GLIPR2 is well conserved among vertebrates and is also known as GAPR-1 and C9orf19 [29, 52] . In man, GLIPR2 has been reported to be expressed particularly by leukocytes and in lung, suggesting a role in immunity [52] . GLIPR2 contains a sperm-coating protein (SCP) domain, also referred to as a CAP domain [53] . However, in contrast to other SCP/CAP domain-containing proteins, such as GLIPR1 and the CRISP (cysteine-rich secretory proteins) proteins, GLIPR2 lacks a signal peptide and therefore cannot be secreted via the classical secretory pathway. Consistent with a cytosolic orientation [54, 55] , we found GLIPR2 to be protected from protease treatment. CRISPs are particularly highly expressed in the male reproductive tract and have been implicated in sperm development, capacitation, motility, and fertilization [56] as well as in protection against phagocytosis by neutrophils [57] . Seminal plasma is known to modulate both innate and acquired immune responses locally within the female reproductive tract to prevent immune-mediated destruction of healthy sperm cells [19] . Apart from anti-inflammatory compounds such as prostaglandin-E and TGFB [58] , prostasomes also appear to have an immunomodulatory role [26, 28] . Similar to its proposed immunomodulatory function in leucocytes, GLIPR2 in prostasomes may help to preventing destruction of sperm by the female reproductive tract.
We identified annexin A1 as a protein that is exclusively associated with the exoplasmic surface of the ;105 nm prostasomes. Annexin A1 is an anti-inflammatory protein that may regulate diverse processes including cell recruitment, phagocytosis, proliferation, and apoptosis [59] . Annexin A1 is FIG. 6 . GLIPR2 locates to the luminal side, while annexin A1 is on the exoplasmic surface of prostasomes. Isolated prostasomes were incubated as indicated either in the absence or presence of proteinase-K and/or CHAPS, and then immunoblotted for GLIPR2 or annexin A1. Annexin-I was already digested by proteinase K in the absence of CHAPS, indicating surface exposure. Digestion of GLIPR2 on the other hand required the additional presence of CHAPS, indicating its presence in the prostasomal lumen.
AALBERTS ET AL. a cytosolic protein that lacks a signal sequence for incorporation into the classical secretory pathway but is known to be released by nonclassical secretion. Annexin A1 is expressed by many cell types but particularly by prostate epithelial cells, which actively and selectively secrete this protein into prostatic fluid [39] . It is possible that annexin A1-carrying prostasomes may help to suppress immune responses in the female reproductive tract in response to sperm. Interestingly, loss of annexin A1 expression by prostate cancer cells correlates with cancer progression [60, 61] .
In conclusion, we have identified two distinct populations of prostasomes with presumably distinct but potentially convergent roles in immunomodulating the response of the female reproductive tract to sperm. The presence or absence of PSCA, annexin A1, and GLIPR2 on prostasomes, together with the proposed correlations between the expression of these proteins and prostate cancer, warrant further investigations on the value of prostasome subtypes as biomarkers for both prostate disease and aspects of fertility.
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